The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells
Author:
Funder
Mashhad University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Link
https://link.springer.com/content/pdf/10.1007/s12013-022-01100-5.pdf
Reference39 articles.
1. Steinhoff, M. S., von Mentzer, B., Geppetti, P., Pothoulakis, C., & Bunnett, N. W. (2014). Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiological reviews, 94(1), 265–301.
2. Saria, A. (1987). The role of substance P and other neuropeptides in transmission of pain. Acta neurochirurgica Supplementum, 38, 33–35.
3. Mantyh, P. W. (2002). Neurobiology of substance P and the NK1 receptor. The Journal of clinical psychiatry, 63(Suppl 11), 6–10.
4. Muñoz, M., Rosso, M., & Coveñas, R. (2010). A new frontier in the treatment of cancer: NK-1 receptor antagonists. Current medicinal chemistry, 17(6), 504–516.
5. Esteban, F., Muñoz, M., González-Moles, M. A., & Rosso, M. (2006). A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer metastasis reviews, 25(1), 137–145.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A study on the efficacy and safety of aprepitant injection in preventing and treating nausea and vomiting induced by platinum‐based chemotherapy in lung cancer;Precision Medical Sciences;2024-01-11
2. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024
3. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant;International Journal of Molecular Sciences;2023-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3